Instruction for use: Tranxene

Dosage form: capsules

Active substance: Dipotassium clorazepate*

ATX

N05BA05 Dicatia clorazepate

Pharmacological group:

Anxiolytics

The nosological classification (ICD-10)

F41 Other anxiety disorders: Anxiety status; Anxiety; Chronic alarm; Sense of anxiety; Anxious-hypothetical states; Stopping an alarm; Nonpsychotic anxiety disorders

F48 Other neurotic disorders: Neurosis; Neurological diseases; Neurotic disorders; Neurotic condition; Psychoneurosis; Anxious-Neurotic Conditions; Chronic neurotic disorders; Emotional reactive disorders

F95 Teaki: Teak child; Children's teak; Nerve Teacks in Children; Nervous teack; Teak

R45.1 Anxiety and agitation: Agitation; Anxiety; Explosive excitability; Internal stimulation; Excitability; Excitation; Excitation acute; Psychomotor agitation; Hyperexcitability; Motor excitement; Cessation of psychomotor agitation; Nervous excitement; Restlessness; Night trouble; Acute stage of schizophrenia with excitation; Acute mental agitation; Paroxysm of excitation; Overexcitation; Increased excitability; Increased nervous excitability; Increased emotional and cardiac excitability; Increased agitation; Mental arousal; Psychomotor agitation; Psychomotor agitation in psychoses; Psychomotor agitation of an epileptic nature; Psychomotor paroxysm; Psychomotor fit; Symptoms of excitation; Symptoms of psychomotor agitation; The state of agitation; A state of anxiety; Excitation status; A state of heightened concern; The state of psychomotor agitation; Conditions of anxiety; Excitation conditions; The state of excitement in somatic diseases; Excitation level; Feelings of anxiety; Emotional arousal

Composition and release form

1 capsule contains clorazepate dicum 5 or 10 mg; in bottles of 30 pcs., in the box 1 bottle.

Pharmachologic effect

Mode of action - anticonvulsant, anxiolytic, miorelaxing, central, sedative.

Indicationsfor the Tranxene

Alarming conditions and their manifestations in adults: anxiety, anxiety, depression; in children: teak, emotional lability, neuroses (due to anxiety conditions); mental and somatic manifestation of anxiety, anguish; Day alarm.

Contraindications

Hypersensitivity, respiratory insufficiency, children's age (up to 2.5 years).

Application in pregnancy and breastfeeding

Contraindicated. For the duration of treatment, breastfeeding should be stopped.

Side effects

Drowsiness, myasthenia gravis, anterograde amnesia, a sense of intoxication, paradoxical phenomena (excitability, aggressiveness, etc.), withdrawal syndrome, skin rash.

Interaction

Before the start of treatment should be a therapy for hypothyroidism, hyperprolactinaemia, tumors of the pituitary gland or hypothalamus.

Dosing and Administration

Inside, with food, under medical supervision. Adults - 5-30 mg / day. In severe cases, up to 50 mg / day or more. Children - 0.5 mg / kg / day in several receptions.

Precautionary measures

Caution is needed when prescribing to patients with depression, myasthenia gravis.

Storage conditions of the drug Tranxene

In the dark place at a temperature of 15-30 ° C.

Keep out of the reach of children.

Shelf life of the drug Tranxene

3 years.

Do not use after the expiry date printed on the package.